Comprehensive Bioinformatics Analysis Reveals PTPN1 (PTP1B) Is a Promising Immunotherapy Target Associated with T Cell Function for Liver Cancer
Journal of Healthcare Engineering · 2023-01 · 2023 (1)
DOI: 10.1155/2023/1533794 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Healthcare Engineering, online erschienen am 27.01.2023. Verfasst von Yihao Zhu und 1 weiteren Autor:innen. Beteiligte Einrichtung: International Research Center for Marine Biosciences, Ministry of Science and Technology, Shanghai Ocean University, Shanghai 201306, China. Hauptthemen laut MEDLINE: T-Lymphocytes, Liver Neoplasms. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Shanghai Municipal Education Commission, Science and Technology Commission of Shanghai Municipality.
Abstract (Originalsprache)
Recently, PTP1B was identified as a novel immune checkpoint whose removal can unleash T cell responses. However, research on the influence of PTP1B as an immune regulator on liver cancer is limited. This study aimed to investigate the immunological correlation and function of PTP1B in liver cancer. The expression profiles and corresponding clinical information of liver cancer patients were obtained from the TCGA and ICGC databases. GSE146115 and GSE98638 retrieved from the GEO database were used for the single‐cell RNA‐seq analysis. The mRNA expression of PTP1B (PTPN1) was increased in patients with most malignancies (all p < 0.05), including liver cancer ( p < 0.001). Furthermore, up‐regulated PTPN1 was connected to advanced tumor stage ( p < 0.05) and worse prognosis ( p < 0.01) in liver cancer. Through Cox regression analysis, PTPN1 was considered as an independent prognosis factor of overall survival ( p < 0.05) and acted as a high‐risk factor (hazard ratio > 1). Gene function and pathway analysis suggested PTPN1 was involved in T cell‐related immune responses. Moreover, a close relationship was also found between PTPN1 expression and immune checkpoints as well as immune cells, especially with T cell‐related checkpoints (all p < 0.001) and T cells (all p < 0.001). Single‐cell RNA‐seq analysis further illustrated that the enrichment of PTPN1 in the T cell population may be linked to its exhaustion in the liver cancer microenvironment. Overall, PTPN1 (PTP1B) closely related to T cell may function as an immunotherapy target for liver cancer.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- International Research Center for Marine Biosciences, Ministry of Science and Technology, Shanghai Ocean University, Shanghai 201306, China.
- Key Laboratory of Exploration and Utilization of Aquatic Genetic Resources, Ministry of Education, Shanghai Ocean University, Shanghai 201306, China.
Förderung
- National Natural Science Foundation of China
- Shanghai Municipal Education Commission
- Science and Technology Commission of Shanghai Municipality
Zitieren
APA
Zhu, Y., & Zu, Y. (2023). Comprehensive Bioinformatics Analysis Reveals PTPN1 (PTP1B) Is a Promising Immunotherapy Target Associated with T Cell Function for Liver Cancer. Journal of Healthcare Engineering, 2023(1). https://doi.org/10.1155/2023/1533794
Vancouver
Zhu Y, Zu Y. Comprehensive Bioinformatics Analysis Reveals PTPN1 (PTP1B) Is a Promising Immunotherapy Target Associated with T Cell Function for Liver Cancer. Journal of Healthcare Engineering. 2023;2023(1). doi:10.1155/2023/1533794
BibTeX
@article{Zhu2023,
author = {Zhu, Yihao and Zu, Yao},
title = {Comprehensive Bioinformatics Analysis Reveals PTPN1 (PTP1B) Is a Promising Immunotherapy Target Associated with T Cell Function for Liver Cancer},
journal = {Journal of Healthcare Engineering},
year = {2023},
volume = {2023},
number = {1},
doi = {10.1155/2023/1533794}
}
EUVIMED